Remdesivir for the Treatment of Covid-19 — Final Report
Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory trac...
Publications
2 shownBaricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably amon...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 9,422
- Institution
- University College London
External Links
Identifiers
- ORCID
- 0000-0001-7954-2926
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.